Ascelia Pharma AB (ACE) NPV

Sell:2.80 SEKBuy:2.90 SEKPrice unchangedNo change

Prices delayed by at least 15 minutes
Sell:2.80 SEK
Buy:2.90 SEK
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:2.80 SEK
Buy:2.90 SEK
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open2.92 SEK
Previous close2.90 SEK
Market capSEK 367.92m
P/E ratio-99999.99
Volume694,526
Dividend yield0.00%
EMS-

Company information

Ascelia Pharma AB is a Sweden-based pharmaceutical company focused on the development of novel oncology therapies. The Company identifies, acquires and develops differentiated, underappreciated and derisked ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue126.82m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Balance sheet 2025

Total assetsSEK 111.94m
Total liabilitiesSEK 12.47m
Net debt-SEK 48.89m

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Lightweight Charts™ provided by https://www.tradingview.com/.